Thermo Fisher Scientific reported quarterly EPS of $5.44, ahead of the $5.20 Zacks Consensus Estimate and up from $5.15 a year ago. The result signals a modest earnings beat and slight year-over-year improvement, supportive of near-term sentiment. The news is likely to move the stock modestly, but it does not include revenue or guidance details.
Thermo Fisher Scientific reported quarterly EPS of $5.44, ahead of the $5.20 Zacks Consensus Estimate and up from $5.15 a year ago. The result signals a modest earnings beat and slight year-over-year improvement, supportive of near-term sentiment. The news is likely to move the stock modestly, but it does not include revenue or guidance details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
